Relay Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Relay Therapeutics, Inc. has filed 494 SEC EDGAR filings since 22 May 2020

SEC filing history

Showing 1-25 of 494 matching filings.

Per page
25
Current page
1
ARS File 001-39385

ARS

Filing date
28 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39385

DEFA14A

Filing date
28 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39385

DEF 14A

Filing date
28 Apr 2026
Reporting date
09 Jun 2026
Next action
Verify source filing
PRE 14A File 001-39385

PRE 14A

Filing date
16 Apr 2026
Reporting date
09 Jun 2026
Next action
Verify source filing
SCHEDULE 13G File 005-92097

SCHEDULE 13G filing

Filing date
13 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Apr 2026
Reporting date
07 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92097

SCHEDULE 13G/A filing

Filing date
27 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92097

SCHEDULE 13G filing

Filing date
19 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Mar 2026
Reporting date
09 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39385

144 filing

Filing date
09 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92097

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92097

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2026
Reporting date
27 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2026
Reporting date
27 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2026
Reporting date
27 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Jan 2026
Reporting date
13 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Jan 2026
Reporting date
13 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Jan 2026
Reporting date
13 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .